Compound with anti-depressive properties used as a mental performance enhancer.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Hydrocodone | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Magnesium sulfate | The therapeutic efficacy of Aniracetam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Aniracetam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Mirtazapine | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Orphenadrine | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Pramipexole | Aniracetam may increase the sedative activities of Pramipexole. |
| Ropinirole | Aniracetam may increase the sedative activities of Ropinirole. |
| Rotigotine | Aniracetam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Aniracetam. |
| Sodium oxybate | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Thalidomide | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Aniracetam. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Aniracetam is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Aniracetam is combined with Phenindione. |
| Warfarin | The risk or severity of adverse effects can be increased when Aniracetam is combined with Warfarin. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Aniracetam is combined with Phenprocoumon. |
| Acenocoumarol | The risk or severity of adverse effects can be increased when Aniracetam is combined with Acenocoumarol. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Aniracetam is combined with 4-hydroxycoumarin. |
| Coumarin | The risk or severity of adverse effects can be increased when Aniracetam is combined with Coumarin. |
| (R)-warfarin | The risk or severity of adverse effects can be increased when Aniracetam is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Aniracetam is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Aniracetam is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Aniracetam is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Aniracetam is combined with Diphenadione. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Aniracetam is combined with Tioclomarol. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Aniracetam is combined with (S)-Warfarin. |
| Ethanol | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Zimelidine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Aniracetam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Aniracetam is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Aniracetam is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Aniracetam is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Aniracetam is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Aniracetam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Aniracetam is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Aniracetam is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Aniracetam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Aniracetam is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Aniracetam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Aniracetam. |
| Zopiclone | The risk or severity of adverse effects can be increased when Aniracetam is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Aniracetam. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Aniracetam. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Aniracetam. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Aniracetam. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Aniracetam. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Aniracetam. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Aniracetam. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Aniracetam. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Aniracetam. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Aniracetam. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Aniracetam. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Aniracetam. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Aniracetam. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Aniracetam. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Aniracetam. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Aniracetam. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Aniracetam. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Aniracetam. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Aniracetam. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Aniracetam. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Aniracetam. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Aniracetam. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Aniracetam. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Aniracetam. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Aniracetam. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Aniracetam. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Aniracetam. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Aniracetam. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Aniracetam. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Aniracetam. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Aniracetam. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Aniracetam. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Aniracetam. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Aniracetam. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Aniracetam. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Aniracetam. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Aniracetam. |